References
- Australian Institute of Health and Welfare 2021. Cancer data in Australia. Cat. no. CAN 122. Canberra: AIHW. Accessed June 2021; https://www.aihw.gov.au/reports/cancer/cancer-data-in-australia/data
- Australian Institute of Health and Welfare 2018. Cancer in Aboriginal & Torres Strait Islander people of Australia. Cat. no. CAN 109 Accessed June 2021; https://www.aihw.gov.au/reports/cancer/cancer-in-indigenous-australians
- Australian Institute of Health and Welfare & Cancer Australia 2011. Lung cancer in Australia: an overview. Cancer series no. 64. Cat. no. CAN 58. Canberra: AIHW
- Crane M, Scott N, O’Hara BJ, et al. Knowledge of the signs and symptoms and risk factors of lung cancer in Australia: mixed methods study. BMC Public Health. 2016;16(1):508
- Scott N, Crane M, Lafontaine M, et al. Stigma as a barrier to diagnosis of lung cancer: patient and general practitioner perspectives. Prim Health Care Res Dev. 2015;16(6):618-22
- Chambers SK, Dunn J, Occhipinti S, et al. A systematic review of the impact of stigma and nihilism on lung cancer outcomes. BMC Cancer. 2012;12(1):184
- Cancer Australia. Risk factors for lung cancer: An overview of the evidence. Cancer Australia, Surry Hills NSW, 2014
- International Agency for Research on Cancer. A review of human carcinogens: personal habits and indoor combustions. Tobacco smoking. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon, France: International Agency for Research on Cancer, 2012
- Kim CH, Lee YC, Hung RJ, et al. Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO). International Journal of Cancer. 2014 Oct 15;135(8):1918-30
- Cancer Australia. Lung cancer – What are the risk factors for lung cancer? Accessed: June 2021; https://www.canceraustralia.gov.au/affected-cancer/cancer-types/lung-cancer/what-are-risk-factors-lung-cancer
- Harris, E. J. A. et al. Diagnosis of asbestos-related lung diseases. Expert Rev Respir Med 13, 241-249, doi:10.1080/17476348.2019.1568875 (2019)
- Olsson, A. C. et al. Exposure to diesel motor exhaust and lung cancer risk in a pooled analysis from case-control studies in Europe and Canada. American Journal of Respiratory and Critical Care Medicine 183, 941-948 (2011)
- Steenland, K. & Ward, E. Silica: A Lung Carcinogen. CA: A Cancer Journal for Clinicians 64, 63-69, doi:10.3322/caac.21214 (2014)
- Workplace Health and Safety Queensland. Silica – Technical guide to managing exposure in the workplace. Accessed: June 2021
- Olsson A, Kromhout H. Occupational cancer burden: the contribution of exposure to process-generated substances at the workplace. Molecular Oncology. 2021;15(3):753-763
- Hoy RF, Brims F. Occupational lung diseases in Australia. Med J Aust. 2017; 10:443-448.
- Cancer Australia. Evidence report for Investigating symptoms of lung cancer: a guide for all health professionals. Cancer Australia, Surry Hills NSW 2020
- Australian Building Codes Board 2018. Indoor Air Quality: Handbook Non-Mandatory Document. Accessed: June 2021
- International Agency for Research on Cancer/World Health Organization. Air pollution and cancer. Lyon, France, 2013
- Ang L, Chan CPY, Yau WP, et al. Association between family history of lung cancer and lung cancer risk: a systematic review and meta-analysis. Lung Cancer. 2020; 148; 129-137
- Smith SM, Campbell NC, MacLeod U, et al. Factors contributing to the time taken to consult with symptoms of lung cancer: a cross-sectional study. Thorax. 2009;64(6):523-31
- Hamilton W. The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. British journal of cancer. 2009;101 Suppl 2:S80-6
- NICE. Lung cancer: diagnosis and management. National Institute for Health and Care Excellence, 2019
- Toyoda Y, Nakayama T, Kusunoki Y, et al. Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography. Br J Cancer. 2008;98(10):1602- 7
- Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5):395-409
- Bradley S, Abraham S, Grice A, et al. Sensitivity of chest X-ray for lung cancer: systematic review. Br J Gen Pract. 2018; 68(suppl 1):bjgp18X696905
Terms of Service
Please read the Terms of Service carefully before using the Investigating symptoms of lung cancer interactive diagnostic tool.
By using the Investigating symptoms of lung cancer interactive diagnostic tool, you agree to be bound by these Terms of Service. If you do not agree to be bound by any of these Terms of Service you are not authorised to use the Investigating symptoms of lung cancer interactive diagnostic tool.
- These Terms of Service form a legally binding agreement between you and the Commonwealth of Australia (represented by Cancer Australia) in relation to your use of the Investigating symptoms of lung cancer interactive diagnostic tool. Our Privacy statement and any other notices on this site (including any disclaimer), are hereby incorporated into these Terms of Service.
Information
- The information in the Investigating symptoms of lung cancer interactive diagnostic tool is presented by Cancer Australia for the purpose of providing health material and information. The information is derived from sources Cancer Australia believes to be accurate and current as at the time of publication, but Cancer Australia reserves the right to correct or update content at any time.
- The material and information is made available on the basis that Cancer Australia is not providing professional advice on a particular matter. You should exercise your own skills and care with respect to your use of the Investigating symptoms of lung cancer interactive diagnostic tool.
- Cancer Australia provides no warranties and makes no representations that the material and information provided (including any linked content) in the Investigating symptoms of lung cancer interactive diagnostic tool is correct, current, complete or reliable.
- You agree to indemnify Cancer Australia against any loss or damage Cancer Australia may suffer, howsoever caused (including through negligence), as a result of, or in connection with, the use or misuse of the Investigating symptoms of lung cancer interactive diagnostic tool or the content by you.
- The Investigating symptoms of lung cancer interactive diagnostic tool contains links to external websites. Those links are provided for convenience only and may not remain current or active. You must make your own decisions about the accuracy, currency, and reliability of information in linked websites and Cancer Australia accepts no responsibility for material or information contained in an external website.
- Your use of the Investigating symptoms of lung cancer interactive diagnostic tool may not be private. Cancer Australia adheres to its privacy statement but no data transmitted over the internet can be guaranteed as totally secure.
General
- These Terms of Service are governed by the laws of the Australian Capital Territory and you submit to the non-exclusive jurisdiction of the Australian Capital Territory.
- If anything in these Terms of Service are void or otherwise unenforceable then it will be severed and the rest of the Terms of Service remain in force.
- A failure or delay by a party to exercise any right or remedy it holds under these Terms of Service or at law does not operate as a waiver of that right.
- Cancer Australia may revise these Terms of Service from time to time.
- These Terms of Service record the entire agreement between the parties in respect of the Investigating symptoms of lung cancer interactive diagnostic tool.
Disclaimer
Cancer Australia develops material and information based on the sources we believe to be accurate and current as at the time of publication. However, Cancer Australia provides no warranties and makes no representations that the material and information provided (including any linked content) in the Investigating symptoms of lung cancer interactive diagnostic tool is correct, current, complete or reliable.
Cancer Australia does not accept or assume liability or responsibility for any injury, loss, damage, cost or expense incurred by use of, reliance on, or interpretation of the information. To the maximum extent permitted by law, you release, indemnify and hold Cancer Australia (and its officers, employees and agents) harmless from and against any and all claims and liability arising out of or in connection with your use of the Investigating symptoms of lung cancer interactive diagnostic tool.